Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/ASCLETIS-PHARMA-INC-46512723/attualita/Ascletis-Pharma-Inc-Annuncia-il-deposito-IND-dell-inibitore-orale-di-3CLpro-ASC11-per-COVID-19-acce-42440965/?utm_source=whatsapp&utm_medium=social&utm_campaign=share